Multiple myeloma: clinical review and diagnostic imaging
EJC Angtuaco, ABT Fassas, R Walker, R Sethi… - Radiology, 2004 - pubs.rsna.org
Multiple myeloma (MM) is a malignant clonal neoplasm of plasma cells of B-lymphocyte origin
that commonly results in overproduction of large amounts of monoclonal immunoglobulins…
that commonly results in overproduction of large amounts of monoclonal immunoglobulins…
Myeloma of the central nervous system: association with high‐risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations
ABT Fassas, F Muwalla, T Berryman… - British journal of …, 2002 - Wiley Online Library
Involvement of the central nervous system (CNS) by multiple myeloma, as defined by the
detection of malignant plasma cells in the cerebrospinal fluid in the presence of suggestive …
detection of malignant plasma cells in the cerebrospinal fluid in the presence of suggestive …
The use of liposomal daunorubicin (DaunoXome) in acute myeloid leukemia
A Fassas, A Anagnostopoulos - Leukemia & lymphoma, 2005 - Taylor & Francis
Altered pharmacokinetics of liposomal formulations of drugs can diminish toxicity and allow
the administration of the encapsulated drug at high doses. The liposomal formulation of …
the administration of the encapsulated drug at high doses. The liposomal formulation of …
Total therapy with tandem transplants for newly diagnosed multiple myeloma
…, D Siegel, G Tricot, N Munshi, A Fassas… - Blood, The Journal …, 1999 - ashpublications.org
Between August 1990 and August 1995, 231 patients (median age 51, 53% Durie-Salmon
stage III, median serum β-2-microglobulin 3.1 g/L, median C-reactive protein 4 g/L) with …
stage III, median serum β-2-microglobulin 3.1 g/L, median C-reactive protein 4 g/L) with …
Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations
…, A Anagnostopoulos, E Montserrat, A Fassas… - Blood, 2007 - ashpublications.org
The chronic lymphocytic leukemia (CLL) immunoglobulin repertoire is biased and
characterized by the existence of subsets of cases with closely homologous (“stereotyped”) …
characterized by the existence of subsets of cases with closely homologous (“stereotyped”) …
[HTML][HTML] Thalidomide and hematopoietic-cell transplantation for multiple myeloma
…, E Rasmussen, F Van Rhee, A Fassas… - … England Journal of …, 2006 - Mass Medical Soc
Background High-dose therapy with melphalan can prolong survival among patients with
multiple myeloma. We assessed whether the addition of thalidomide, which has activity against …
multiple myeloma. We assessed whether the addition of thalidomide, which has activity against …
[HTML][HTML] Autologous hematopoietic stem cell transplantation for autoimmune diseases: an observational study on 12 years' experience from the European Group for …
Background Autologous hematopoietic stem cell transplantation has been used since 1996
for the treatment of severe autoimmune diseases refractory to approved therapies. We …
for the treatment of severe autoimmune diseases refractory to approved therapies. We …
Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells
…, F Muwalla, F van Rhee, A Fassas… - Blood, The Journal …, 2002 - ashpublications.org
Bone marrow plasma cells (PCs) from 74 patients with newly diagnosed multiple myeloma (MM),
5 with monoclonal gammopathy of undetermined significance (MGUS), and 31 healthy …
5 with monoclonal gammopathy of undetermined significance (MGUS), and 31 healthy …
Results of autologous stem cell transplant in multiple myeloma patients with renal failure
…, R Desikan, MJ Shaver, A Fassas… - British journal of …, 2001 - Wiley Online Library
Data are presented on 81 multiple myeloma (MM) patients with renal failure (creatinine >
176·8 μmol/l) at the time of autologous stem cell transplantation (auto‐SCT), including 38 …
176·8 μmol/l) at the time of autologous stem cell transplantation (auto‐SCT), including 38 …
[HTML][HTML] G-CSF–primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous …
…, E Proya, A Anagnostopoulos, A Fassas - Experimental …, 2005 - Elsevier
OBJECTIVE: On the basis of the recently recognized potential of bone marrow (BM) cells to
give rise to hepatocytes, we investigated the possibility that granulocyte colony-stimulating …
give rise to hepatocytes, we investigated the possibility that granulocyte colony-stimulating …